The short version
11 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
isoproterenol hydrochloride · ISOPROTERENOL HYDROCHLORIDE 1 mg/5mL · Injection, Solution · Intravenous · Gland Pharma Limited
NDC 68083-0586-10 · 10 VIAL in 1 CARTON / 5 mL in 1 VIAL · ANDA · View full market →
11 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ISOPROTERENOL HYDROCHLORIDE .2 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Nordic Pharma, Inc. | ISOPROTERENOL HYDROCHLORIDE .2 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Amneal Pharmaceuticals LLC | ISOPROTERENOL HYDROCHLORIDE 1 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Amneal Pharmaceuticals LLC | ISOPROTERENOL HYDROCHLORIDE .2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Avenacy, Inc. | ISOPROTERENOL HYDROCHLORIDE .2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Cipla USA Inc. | ISOPROTERENOL HYDROCHLORIDE 1 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Cipla USA Inc. | ISOPROTERENOL HYDROCHLORIDE .2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | ISOPROTERENOL HYDROCHLORIDE .2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | ISOPROTERENOL HYDROCHLORIDE 1 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Gland Pharma Limited | ISOPROTERENOL HYDROCHLORIDE 1 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Gland Pharma Limited | ISOPROTERENOL HYDROCHLORIDE .2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| KVK-Tech, Inc. | ISOPROTERENOL HYDROCHLORIDE .2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | ISOPROTERENOL HYDROCHLORIDE .2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Amphastar Pharmaceuticals, Inc. | ISOPROTERENOL HYDROCHLORIDE .2 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
| Nexus Pharmaceuticals LLC | ISOPROTERENOL HYDROCHLORIDE .2 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "isoproterenol hydrochloride — NDC 68083-0586-10," retrieved September 3, 2026, https://drugdashboards.com/drug/68083058610.
Free to cite with attribution — see how the data is put together.